GLP-1 medications may affect the nerves and blood vessels of your eyes Although taking a GLP-1 medication was linked to a higher risk of optic nerve disorders, researchers found that the overall risk is still quite low
Some experts even tentatively suggest its possible that GLP-1s could help those with a restrictive eating disorder, such as anorexia nervosa or orthorexia (an unhealthy obsession with healthy eating)
Find articles by Lorenzen-Schmidt, I
RELATED: Can you start Wegovy at 2.4 mg
For the estimated 25 to 35 percent of prospective GLP-1 patients who cite needle aversion as a primary barrier to starting treatment this format is clinically meaningful

At a glance Direct drug interaction / not documented in clinical databases Primary concern / pharmacodynamic overlap (cortisol, thyroid, GABA pathways) Ashwagandha cortisol reduction / 14.5% to 27.9% decrease in two RCTs Thyroid effect / ashwagandha raised T4 by 19.6% in subclinical hypothyroid patients over 8 weeks Vyvanse metabolism / prodrug hydrolyzed in red blood cells, not CYP-dependent Dose-separation recommendation / take ashwagandha at bedtime, Vyvanse in the morning Monitoring / thyroid panel and heart rate at baseline, then every 3 to 6 months Bottom line / likely safe for most adults with prescriber awareness and periodic labs Why This Question Matters Ashwagandha (Withania somnifera) is one of the top-selling herbal supplements in the United States, with sales exceeding $198 million in 2022 according to the American Botanical Council